Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02433990 · ClinicalTrials.gov registry record
Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 178
- Enrollment target
NCT02433990: Completed study, sponsored by Stanford University.
NCT02433990 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02433990 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 178 participants
- Enrollment target
Study Summary
This research study is to determine the risk factors for acquired heart disease, in adults with congenital heart disease. This knowledge is important to develop and target ways to prevent or delay the onset of acquired heart disease in adults with congenital heart disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2014-04 |
| Est. Completion | 2019-08-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02433990
The ClinicalTrials.gov registry entry for NCT02433990 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02433990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02433990 about?
NCT02433990 is a clinical study titled "Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease". This research study is to determine the risk factors for acquired heart disease, in adults with congenital heart disease. This knowledge is important to develop and target ways to prevent or delay the onset of acquired heart disease in adults with congenital heart disease.
What is the current status of trial NCT02433990?
This trial is currently completed. The enrollment target is 178 participants. The study started on 2014-04. Estimated completion is 2019-08-24.
Who is sponsoring clinical trial NCT02433990?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.